MA52880A - Composition d'hydrogel comprenant un polymère réticulé - Google Patents

Composition d'hydrogel comprenant un polymère réticulé

Info

Publication number
MA52880A
MA52880A MA052880A MA52880A MA52880A MA 52880 A MA52880 A MA 52880A MA 052880 A MA052880 A MA 052880A MA 52880 A MA52880 A MA 52880A MA 52880 A MA52880 A MA 52880A
Authority
MA
Morocco
Prior art keywords
cross
composition containing
linked polymer
hydrogel composition
hydrogel
Prior art date
Application number
MA052880A
Other languages
English (en)
Inventor
Ralph Hollaus
Martin Prinz
Robert Sachsenhofer
Original Assignee
Croma Pharma Ges M B H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croma Pharma Ges M B H filed Critical Croma Pharma Ges M B H
Publication of MA52880A publication Critical patent/MA52880A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
MA052880A 2018-06-15 2019-06-14 Composition d'hydrogel comprenant un polymère réticulé MA52880A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18178099 2018-06-15
EP18178097 2018-06-15
EP18178098 2018-06-15

Publications (1)

Publication Number Publication Date
MA52880A true MA52880A (fr) 2021-09-22

Family

ID=66821271

Family Applications (2)

Application Number Title Priority Date Filing Date
MA052877A MA52877A (fr) 2018-06-15 2019-06-14 Acide hyaluronique stabilisé
MA052880A MA52880A (fr) 2018-06-15 2019-06-14 Composition d'hydrogel comprenant un polymère réticulé

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA052877A MA52877A (fr) 2018-06-15 2019-06-14 Acide hyaluronique stabilisé

Country Status (13)

Country Link
US (2) US12458582B2 (fr)
EP (2) EP3806919B1 (fr)
JP (2) JP7374133B2 (fr)
KR (2) KR20210021362A (fr)
CN (3) CN112334165A (fr)
BR (2) BR112020024637B1 (fr)
CA (2) CA3101410A1 (fr)
ES (1) ES2983810T3 (fr)
IL (2) IL279445B2 (fr)
MA (2) MA52877A (fr)
MX (1) MX2020013000A (fr)
PL (1) PL3806919T3 (fr)
WO (2) WO2019238955A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7374133B2 (ja) 2018-06-15 2023-11-06 クロマ－ファーマ ゲゼルシャフト エム．ベー．ハー． 安定化されたヒアルロン酸
EP3806917B1 (fr) 2018-06-15 2025-12-10 Croma-Pharma GmbH Composition d'hydrogel comprenant un polymère réticulé
EP4077402B1 (fr) * 2019-12-19 2024-05-01 Croma-Pharma GmbH Hyaluronane modifié par thiol et hydrogel comprenant l'hyaluronane réticulé
EP4090317A4 (fr) * 2020-01-16 2024-02-21 The Hong Kong University of Science and Technology Compositions et procédés pour la libération contrôlée d'un agent cible
CN115702937B (zh) * 2021-08-04 2024-12-17 四川大学 改性多酚载体材料、靶向纳米递送系统及制备方法和用途
KR20230145624A (ko) * 2022-04-08 2023-10-18 (주)아크로스 안전성이 우수한 조직수복용 생체재료의 제조 방법
CN115414276A (zh) * 2022-06-24 2022-12-02 辽宁德玛生物科技有限公司 一种注射用琼脂糖凝胶剂及其制备方法
TWI840941B (zh) * 2022-09-06 2024-05-01 科妍生物科技股份有限公司 製造自體交聯透明質酸凝膠之方法及其產物
IT202200023682A1 (it) 2022-11-16 2024-05-16 Francesco Bernardini Composizioni e metodi per migliorare difetti volumetrici del viso
WO2024113006A1 (fr) * 2022-11-28 2024-06-06 Telethon Kids Institute Nouveaux hydrogels
CN117298355B (zh) * 2023-11-28 2024-03-08 常州百瑞吉生物医药股份有限公司 一种包裹性透明质酸凝胶组合物及其制备方法与应用
CN121695258A (zh) * 2026-02-10 2026-03-20 常州百瑞吉生物医药股份有限公司 无色透明的重组人源化胶原蛋白-巯基化透明质酸复合水凝胶及其制备方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
CA2416126C (fr) 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Composites bioabsorbables d'acide hyaluronique derive
WO2002056914A1 (fr) 2001-01-19 2002-07-25 Hironori Yamamoto Injections destinees a une endoscopie
EP1368309B2 (fr) 2001-02-22 2014-10-01 Anika Therapeutics Inc. Derives d'hyaluronane thiol-modifies
GB2386900B (en) 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
CA2489712C (fr) 2002-06-21 2016-07-12 University Of Utah Research Foundation Composes reticules et leurs procedes de preparation et d'utilisation
AU2004297231B2 (en) 2003-12-04 2012-02-02 University Of Utah Research Foundation Modified macromolecules and associated methods of synthesis and use
CN101921347B (zh) 2004-01-07 2014-07-30 生化学工业株式会社 透明质酸衍生物及含有其的药剂
TW200536861A (en) 2004-04-02 2005-11-16 Denki Kagaku Kogyo Kk Hyaluronic acid/methotrexate compound
TW200612991A (en) 2004-09-07 2006-05-01 Chugai Pharmaceutical Co Ltd Process for producing water-soluble hyaluronic acid modification
ITPD20050242A1 (it) 2005-08-03 2007-02-04 Fidia Farmaceutici Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
CN101287475B (zh) 2005-09-07 2012-11-14 阿尔卡米亚肿瘤学股份有限公司 包含透明质酸和治疗抗体的治疗组合物以及制药用途
WO2008008857A2 (fr) 2006-07-11 2008-01-17 University Of Utah Research Foundation Macromolécules thiolées et procédés de fabrication et d'utilisation de celles-ci
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
CN101200504B (zh) 2006-12-11 2010-05-12 上海百瑞吉生物医药有限公司 高分子巯基化改性衍生物及其交联材料
SI2107913T1 (sl) 2006-12-22 2012-05-31 Croma Pharma Ges M B H Uporaba tioliranih polisaharidov za tkivno avgmentacijo
CA2686505A1 (fr) * 2007-05-11 2008-11-20 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2008148071A2 (fr) 2007-05-24 2008-12-04 Nidus2, Llc Derme injectable
WO2009005790A2 (fr) * 2007-06-29 2009-01-08 Carbylan Biosurgery, Inc. Compositions stériles de polymère d'acide hyaluronique et procédés correspondants
US20110038939A1 (en) * 2007-07-16 2011-02-17 Northeastern University Therapeutic stable nanoparticles
US9161970B2 (en) 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
EP2254610A4 (fr) 2008-02-22 2013-07-31 Dermal Technologies Llc Compositions pour augmentation de tissus
EP3456749B1 (fr) 2008-02-29 2021-07-14 PVAC Medical Technologies Ltd. Réactif d'alcool polyvinyl substitué
US20090269417A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Thiolated chitosan gel
CN101367884A (zh) * 2008-09-25 2009-02-18 复旦大学 一种半胱胺修饰的巯基化透明质酸偶合物及其制备方法和应用
CN101721349B (zh) * 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
MX2011009855A (es) 2009-03-23 2011-10-06 Genzyme Corp Reparacion de cartilago.
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CN102399295B (zh) 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
AU2012262047A1 (en) 2011-06-03 2014-01-16 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
KR20220013588A (ko) * 2011-09-14 2022-02-04 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물
CA2858366C (fr) 2011-12-08 2020-01-21 Allergan Industrie, Sas Compositions de remplissage dermal optiquement transparentes renfermant un acide hyaluronique reticule avec des diamines ou des multiamines
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
WO2014181147A1 (fr) 2013-05-08 2014-11-13 Allergan Industrie Gels d'acide hyaluronique réticulés par du trimétaphosphate de sodium
RU2640865C2 (ru) * 2013-06-28 2018-01-12 Гальдерма С.А. Способ производства формованного продукта из поперечно-сшитой гиалуроновой кислоты
ITMI20131193A1 (it) * 2013-07-16 2015-01-17 Ira Srl Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico
WO2016005785A1 (fr) 2014-07-11 2016-01-14 Allergan Industrie, Sas Gels d'acide hyaluronique réticulés par du trimétaphosphate de sodium
CN104892962B (zh) * 2015-06-05 2017-12-08 四川大学 一种巯基/二硫键可控自交联透明质酸水凝胶的制备方法及其应用
IT201600096125A1 (it) * 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee
AR110125A1 (es) 2016-11-07 2019-02-27 Croma Pharma Ges M B H Compuestos poliméricos que liberan sulfuro de hidrógeno
CN108465128B (zh) 2018-03-01 2021-03-16 杭州协合医疗用品有限公司 一种交联透明质酸细胞支架材料的制备方法
JP7374133B2 (ja) 2018-06-15 2023-11-06 クロマ－ファーマ ゲゼルシャフト エム．ベー．ハー． 安定化されたヒアルロン酸

Also Published As

Publication number Publication date
IL279446B2 (en) 2025-05-01
JP7374133B2 (ja) 2023-11-06
KR20210021363A (ko) 2021-02-25
WO2019238954A1 (fr) 2019-12-19
EP3806919A1 (fr) 2021-04-21
KR102852956B1 (ko) 2025-09-03
IL279446B1 (en) 2025-01-01
US20210259943A1 (en) 2021-08-26
CN116650519A (zh) 2023-08-29
CN112334165A (zh) 2021-02-05
CA3101410A1 (fr) 2019-12-19
JP2021526934A (ja) 2021-10-11
US20210260243A1 (en) 2021-08-26
BR112020024637A2 (pt) 2021-03-02
US12097277B2 (en) 2024-09-24
BR112020024637B1 (pt) 2024-01-30
BR112020024735B1 (pt) 2024-02-27
KR20210021362A (ko) 2021-02-25
US12458582B2 (en) 2025-11-04
CN112334167A (zh) 2021-02-05
WO2019238955A1 (fr) 2019-12-19
MA52877A (fr) 2021-04-21
BR112020024735A2 (pt) 2021-03-23
ES2983810T3 (es) 2024-10-24
EP3806919B1 (fr) 2024-05-15
CA3101412A1 (fr) 2019-12-19
EP3806918A1 (fr) 2021-04-21
MX2020013000A (es) 2021-03-29
IL279445B2 (en) 2025-05-01
IL279445A (en) 2021-01-31
IL279446A (en) 2021-01-31
JP2021526933A (ja) 2021-10-11
PL3806919T3 (pl) 2024-10-28
IL279445B1 (en) 2025-01-01

Similar Documents

Publication Publication Date Title
IL279446A (en) A hydrogel-based preparation containing a cross-linked polymer
IL281539A (en) Modulating polymer beads for dna processing
EP3846698A4 (fr) Dispositif de chargement d'endoprothèse
EP3888708A4 (fr) Particules d'hydrogel pour chimioembolisation comprenant un polymère biodégradable
MA52876A (fr) Composition d'hydrogel comprenant un polymère réticulé
EP3870257A4 (fr) Accouplement d'unités de cartouche
EP3754750A4 (fr) Dispositif d'aération
EP3677628A4 (fr) Composition polymère super-absorbante
EP3882181A4 (fr) Système d'entreposage
EP3885377A4 (fr) Polymère à base d'oléfine
EP3449913A4 (fr) Timbre d'hydrogel
EP3900909A4 (fr) Dispositif d'extrusion
EP3747914A4 (fr) Coagulats de polymère acrylique
EP3950737A4 (fr) Composition de résine de polyamide comprenant un ionomère spécifique
PL3898727T3 (pl) Elastyczny elektrolit polimerowy
EP3764160A4 (fr) Pellicule comprenant un film de graphite
DK3674340T3 (da) Manganbærende polymerkomplekser
EP3882278A4 (fr) Composition polymère
IL289229A (en) Moulded polyurethane hydrogels
EP4063446A4 (fr) Composition de polymère
EP4010400A4 (fr) Points polymères
EP3823560A4 (fr) Compositions polymères ioniques
GB2572865B (en) Polymeric film
EP3770212A4 (fr) Composition polymère à base de butène
EP3825120A4 (fr) Film d'encapsulation